Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Mannitol for Bronchiectasis (B305)
NCT00669331Phase 3Completed
- Sponsor
- Syntara Limited
- Start
- Nov 2009
- Primary completion
- Jan 2014
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of Bronchitol in bronchiectasis, sponsored by Syntara Limited. Started Nov 2009; status: completed.
02
Drugs
Bronchitol
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT00669331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669331.